Form 4: CFO Ben Taylor's Tax-Related Stock Transaction

CFO Ben Taylor reports 7,057 share disposition for tax withholding.

Summary

• Ben R. Taylor, Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. (RXRX), reported a transaction.
• The transaction involved the disposition of 7,057 shares of Class A Common Stock on September 15, 2025.
• These shares were withheld by the Issuer to satisfy tax withholding and remittance obligations related to the net settlement of restricted stock units.
• The price per share for the disposed securities was $4.83.
• Following this transaction, Ben R. Taylor beneficially owns 804,169 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary disposition of shares for tax withholding purposes related to restricted stock unit vesting. It does not reflect a discretionary sale or purchase by management and therefore carries a neutral sentiment regarding the company's prospects.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports a routine, non-discretionary insider transaction related to compensation and tax obligations, which is common across all industries for executives receiving equity-based compensation. It does not provide insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of management's sentiment on the stock's future.

Key Dates

Keywords

Recursion Pharmaceuticals, RXRX, Ben Taylor, CFO, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units